John Hood

Active 1976–2026

Affiliations
Glasgow Caledonian UniversityThis corpus build does not record the country of an author's affiliations, so none is shown here. It does not mean these institutions have no country.
38
Papers
9,314
Citations
31
h-index
34
i10-index

Self-citations are included in these numbers.

Citations per year

Citations

Citations per year for John Hood1977: 3 citations1978: 2 citations1979: 1 citations1980: 1 citations1981: 2 citations1982: 2 citations1984: 2 citations1985: 3 citations1986: 2 citations1988: 2 citations1989: 1 citations1990: 2 citations1992: 1 citations1994: 1 citations1996: 1 citations1997: 3 citations1998: 6 citations1999: 33 citations2000: 44 citations2001: 71 citations2002: 76 citations2003: 133 citations2004: 163 citations2005: 143 citations2006: 148 citations2007: 127 citations2008: 162 citations2009: 150 citations2010: 141 citations2011: 125 citations2012: 102 citations2013: 93 citations2014: 61 citations2015: 54 citations2016: 44 citations2017: 59 citations2018: 46 citations2019: 188 citations2020: 210 citations2021: 203 citations2022: 152 citations2023: 127 citations2024: 148 citations2025: 57 citations2026: 1 citations1983: no citations, so this year is not shown1987: no citations, so this year is not shown1991: no citations, so this year is not shown1993: no citations, so this year is not shown1995: no citations, so this year is not shown

Citation sources

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Fields

  • Medicine48.4%
  • Biochemistry, Genetics and Molecular Biology36.1%
  • Materials Science4.2%
  • Immunology and Microbiology3.1%
  • Neuroscience2.7%
  • Engineering2.1%
  • Other3.4%

Topics

  • Angiogenesis and VEGF in Cancer20.8%
  • Cell Adhesion Molecules Research17.9%
  • Osteoarthritis Treatment and Mechanisms6.3%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment5.8%
  • Cancer, Hypoxia, and Metabolism5.4%
  • Nanoparticle-Based Drug Delivery5.3%
  • Other38.5%

Frequent coauthors

All papers

Loading papers…

John Hood | Litlas